VIVALIS Aktie

5,15 EUR -0,3868%

Zu Ihrem Onlinebroker

kaufen verkaufen

VIVALIS Aktienkurs : 17:04 ( 15 Min. verzögert)
5,15 € Letzter Kurs	-0,39% Veränderung	5,17 € Vortag	5,25 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
5,25 - 5,10 Tag	8,20 - 4,40 52 Wochen	18.101 Tag	27.060 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

VIVALIS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

VIVALIS : PHASE II CLINICAL TRIAL FOR A HUMAN INFLUENZA VACCINE INITIATED

Nantes, Lyon (France) - May 24th, 2012, VIVALIS (NYSE Euronext: VLS) today announced that Kaketsuken has commenced a phase 2 clinical trial in Japan in April 2012 for...
16.05.

Global Human Vaccines Industry

... Acambis II-112Novartis to Acquire Protez II-112Novartis Inks Agreement with AlphaVax II-113Vacsera Signs Agreement with Omninvest II-113GeoVax Sign LOI with Vivalis II-113GlaxoSmithKline Receives EC Approval for Prepandrix Vaccine II-114ShigaMedix ...

11.05.

BioDiem inks research collaboration with Vivalis to test production of LAIV ...

Australian vaccine development company, BioDiem Ltd has begun a research collaboration with France-based Vivalis, a biopharmaceutical company with expertise in vaccine production technologies. The collaboration involves investigation of the synergy of ...
02.05.

West Island Palliative Care Residence provides 14 new beds

The announcement was made at the first floor of Le Vivalis personal care facility of which the new Pavilion Stillview occupies the fourth floor on Stillview Road at the corner of...